Organization · Venture Capital
Cell Rising Capital
Cell Rising Capital is a Hong Kong-based venture capital firm that specializes in early-stage funding for startups across Europe and Asia, focusing on advanced technologies such as AI, biotech, and fintech.
Overview
What Cell Rising Capital does
What Cell Rising Capital is
Cell Rising Capital is a Hong Kong-based venture capital firm that specializes in early-stage funding for startups across Europe and Asia, focusing on advanced technologies such as AI, biotech, and fintech.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2020
- Approximate age
- About 6 years
- Structured capabilities
- Funder
- Last reviewed
- April 26, 2026
Official channels
Find Cell Rising Capital elsewhere
Open the official website or a supported primary organization account.
Capability profile
Cell Rising Capital as a funder
Investment thesis
Cell Rising Capital backs early-stage companies building transformative or advanced technologies, focusing on connecting European and Asian technology markets.
Focus narrative
Cell Rising Capital invests in diverse sectors including advanced manufacturing, artificial intelligence (AI), biotechnology (biotech), electric vehicles (EV), financial technology (fintech), medical technology (medtech), and sustainability. The firm targets startups in the early stages of development, specifically from angel to Series A funding, emphasizing cross-border collaboration.
Value beyond capital
Cell Rising Capital provides not only financial backing but also strategic advice and support through a network of advisors and experts, helping portfolio companies navigate cross-border technology markets and enhance their growth potential.
Focus and fit
- Stages
- Angel · Pre-seed · Seed · Series A
- Sectors
- Artificial IntelligenceBiotech & Life SciencesFintechHealthcareEnergyConsumerMobility & TransportationIndustrial & ManufacturingClimate & Sustainability
- Regions
- Global · Asia · Europe
Availability
- Currently deploying
- Not published
Portfolio and track record
Portfolio context
Notable projects associated with Cell Rising Capital include: Hex Trust: A digital-asset custody and infrastructure company based in Hong Kong. Wrisk: A London-based insurtech company that raised approximately EUR 5.3 million for innovative automotive insurance solutions. audioXpress: A collaboration between Audioscenic and AIStorm to deliver cost-effective position-sensing 3D sound.
Common questions
What to know about Cell Rising Capital
Upseed classifies Cell Rising Capital under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 26, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.